B. Bui-Nguyen

2.9k total citations
13 papers, 444 citations indexed

About

B. Bui-Nguyen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, B. Bui-Nguyen has authored 13 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in B. Bui-Nguyen's work include Sarcoma Diagnosis and Treatment (11 papers), Vascular Tumors and Angiosarcomas (6 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). B. Bui-Nguyen is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), Vascular Tumors and Angiosarcomas (6 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). B. Bui-Nguyen collaborates with scholars based in France, United States and Netherlands. B. Bui-Nguyen's co-authors include Jean‐Yves Blay, Nicolas Penel, Christine Chevreau, Nicolás Isambert, Ivana Galetić, Yanzhi Hsu, Florence Duffaud, Piotr Rutkowski, Isabelle Ray‐Coquard and María Rios and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

In The Last Decade

B. Bui-Nguyen

13 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Bui-Nguyen France	10	340	187	162	94	78	13	444
P. Chalabreysse France	3	346 1.0×	122 0.7×	145 0.9×	110 1.2×	32 0.4×	9	426
M. M. Van Glabbeke Netherlands	5	480 1.4×	288 1.5×	202 1.2×	175 1.9×	79 1.0×	8	573
Sławomir Falkowski Poland	11	237 0.7×	56 0.3×	193 1.2×	60 0.6×	44 0.6×	38	355
Anna Klimczak Poland	12	202 0.6×	106 0.6×	149 0.9×	51 0.5×	24 0.3×	32	328
A. Le Cesne France	10	194 0.6×	106 0.6×	181 1.1×	57 0.6×	56 0.7×	41	369
Philip Ströbel Germany	7	158 0.5×	59 0.3×	174 1.1×	101 1.1×	39 0.5×	9	291
C. Piovesan Italy	6	329 1.0×	36 0.2×	153 0.9×	36 0.4×	31 0.4×	7	373
Julie Meade United States	6	284 0.8×	326 1.7×	54 0.3×	140 1.5×	104 1.3×	8	403
A. Van Den Abbeele United States	8	191 0.6×	155 0.8×	54 0.3×	49 0.5×	63 0.8×	16	332
Jiro Shimazaki Japan	13	134 0.4×	77 0.4×	260 1.6×	289 3.1×	53 0.7×	41	683

Countries citing papers authored by B. Bui-Nguyen

Since Specialization

Citations

This map shows the geographic impact of B. Bui-Nguyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Bui-Nguyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Bui-Nguyen more than expected).

Fields of papers citing papers by B. Bui-Nguyen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Bui-Nguyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Bui-Nguyen. The network helps show where B. Bui-Nguyen may publish in the future.

Co-authorship network of co-authors of B. Bui-Nguyen

This figure shows the co-authorship network connecting the top 25 collaborators of B. Bui-Nguyen. A scholar is included among the top collaborators of B. Bui-Nguyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Bui-Nguyen. B. Bui-Nguyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Coindre, Jean‐Michel, Françoise Ducimetière, Simone Mathoulin‐Pélissier, et al.. (2016). Illustration de partenariat public/privé. Prises en charge des sarcomes des tissus mous en France–une analyse rétrospective de la « base clinico-biologique sarcomes ». Revue d Épidémiologie et de Santé Publique. 64. S278–S278. 1 indexed citations

Bui-Nguyen, B., James E. Butrynski, Nicolas Penel, et al.. (2015). A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial. European Journal of Cancer. 51(10). 1312–1320. 59 indexed citations

Patrikidou, Anna, Julien Dômont, Sylvie Chabaud, et al.. (2015). Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group. European Journal of Cancer. 52. 173–180. 63 indexed citations

Khalifa, Jonathan, M. Ouali, Léonor Chaltiel, et al.. (2015). Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group. BMC Cancer. 15(1). 700–700. 36 indexed citations

Adenis, Antoine, Jean‐Yves Blay, B. Bui-Nguyen, et al.. (2014). Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial. Annals of Oncology. 25(9). 1762–1769. 57 indexed citations

Adenis, Antoine, Isabelle Ray‐Coquard, Antoîne Italiano, et al.. (2013). A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours. British Journal of Cancer. 109(10). 2574–2578. 21 indexed citations

Cousin, Sophie, Jean‐Yves Blay, François Bertucci, et al.. (2013). Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma Group. Annals of Oncology. 24(10). 2681–2685. 17 indexed citations

Reichardt, Peter, Jean‐Yves Blay, Hans Gelderblom, et al.. (2012). Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib. Annals of Oncology. 23(7). 1680–1687. 97 indexed citations

Duffaud, Florence, et al.. (2012). A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcoma. European Journal of Cancer. 48(4). 564–570. 29 indexed citations

10.

Bui-Nguyen, B., I. Ray-Coquard, Christine Chevreau, et al.. (2011). High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial. Annals of Oncology. 23(3). 777–784. 21 indexed citations

11.

Italiano, Antoîne, Maud Toulmonde, & B. Bui-Nguyen. (2010). [Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines].. PubMed. 97(6). 679–86. 5 indexed citations

12.

Bui-Nguyen, B., et al.. (2010). [Adjuvant chemotherapy of adults soft tissue sarcomas].. PubMed. 97(6). 673–8. 1 indexed citations

13.

Fayette, Jérôme, Nicolas Penel, Christine Chevreau, et al.. (2009). Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma. Investigational New Drugs. 27(5). 482–489. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact